Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal fixation systems. They aim to improve patient outcomes and surgeon experiences with innovative products for spinal, orthopedic, and oral maxillofacial procedures.
Corporate headquarters, housing executive leadership, administrative functions, research and development, manufacturing of orthobiologics and spinal implants, and quality control operations.
The Belgrade facility spans approximately 39,000 square feet, including specialized cleanrooms for biologic tissue processing, advanced manufacturing areas for medical devices, R&D laboratories, and warehouse space.
The work culture at Xtant Medical likely emphasizes innovation in medical technology, precision in manufacturing processes, a strong focus on quality and regulatory compliance, and a collaborative environment geared towards improving patient care.
This headquarters is the central hub for Xtant Medical's strategic operations, product innovation, manufacturing excellence, and distribution, playing a critical role in their mission to provide advanced surgical solutions.
Xtant Medical operates with a global mindset, with its primary manufacturing and R&D centered in the USA (Belgrade, MT). It extends its commercial reach through a sales and marketing office in Pennsylvania, USA, and an international distribution hub in Karlsruhe, Germany, enabling the company to serve healthcare markets in North America and Europe with its specialized orthobiologics and spinal fixation systems.
600 Cruiser Lane
Belgrade
Montana
USA
Address: Specific street address not publicly listed; approximately 1,600 sq ft of office space.
Focuses on enhancing market penetration, building relationships with healthcare professionals, and driving sales growth, particularly in the eastern United States.
Address: Specific street address not publicly listed; approximately 3,200 sq ft of warehouse and office space.
Supports international sales and distribution operations in Europe, ensuring timely product availability and logistical support for European distributors and customers.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Xtant Medical' leadership includes:
Xtant Medical has been backed by several prominent investors over the years, including:
In the past year, Xtant Medical strengthened its operational leadership with the appointment of Mark Schallenberger as Chief Operating Officer in March 2023. The core executive team has otherwise maintained stability with no other major C-suite hires or departures publicly announced during this period.
Discover the tools Xtant Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Xtant Medical primarily utilizes the email format [first_initial][last]@xtantmedical.com (e.g., jdoe@xtantmedical.com). While other formats may exist within the organization, this pattern is the most commonly observed for employee email addresses.
[first_initial][last]@xtantmedical.com
Format
jdoe@xtantmedical.com
Example
70%
Success rate
GlobeNewswire • May 7, 2024
Xtant Medical reported Q1 2024 total revenue of $26.2 million, a 42% increase year-over-year, attributed to robust growth in fixation revenue and contributions from new product launches. The company also reaffirmed its full-year 2024 revenue guidance....more
GlobeNewswire • February 27, 2024
Xtant Medical announced the full market availability of Simplix™ Flowable Allograft, an advanced bone graft substitute offering osteoconductive, osteoinductive, and osteogenic properties, designed for ease of use in a variety of orthopedic surgical procedures....more
GlobeNewswire • November 7, 2023
Xtant Medical reported $22.0 million in revenue for the third quarter of 2023, marking a 46% increase compared to the same period in the previous year. This growth was driven by strong performance in its fixation and biologics product lines and the successful integration of acquired assets....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Xtant Medical, are just a search away.